Extension Study to Investigate the Efficacy, Safety, and Tolerability of Eslicarbazepine Acetate (BIA 2-093) in the Recurrence Prevention of Bipolar I Disorder [EXTENSION OF 700231317]
Latest Information Update: 07 Sep 2021
Price :
$35 *
At a glance
- Drugs Eslicarbazepine acetate (Primary)
- Indications Bipolar I disorders
- Focus Therapeutic Use
- Sponsors Bial
- 15 Apr 2013 New trial record